Currently browsing the Research Category

Posts about scientific research and development as well as science and engineering breakthroughs.
Recommended posts: R&D Spending in USA Universities - Diplomacy and Science Research - Research Career in Industry or Academia - New Understanding of Human DNA - Basic Science Research Funding - The Worlds Best Research Universities - Mystery of High-Temperature Superconductivity - Why Most Published Research Findings Are False

Webcasts on the Human Microbiome

The human microbiome is a very interesting aspect of our health and biology.

The 99% figure they quote is mainly silly. It might be technically accurate, but it is much more misleading than accurate (if it is accurate). We have more non-human cells than human but those cells are much smaller and we are overwhelmingly made up of human cells by weight (95+%).

The complexity of healthy bodies is far from understood. It is interesting to watch our understanding of the balancing act going on inside of us. Many foreign “invaders” are critical to our health.

Related: People are Superorganisms With Microbiomes of Thousands of SpeciesPeople Have More Bacterial Cells than Human CellsFighting Superbugs with Superhero BugsWe Have Thousands of Viruses In Us All the Time

Continue reading

Using Diatom Algae to Deliver Chemotherapy Drugs Directly to Cancer Cells

I am thankful for scientists doing the time consuming and important research to find new ways to fight disease. Here is an interesting webcast discussing how chemotherapy is used to fight cancer and how scientists are looking to algae to deliver the chemotherapy drugs to better target cancer cells (while not savaging our health cells).

I am also thankful to the funding sources that pay for this research (and for cool explanations of science, like SciShow).

Read more about the genetically engineered algae kills 90% of cancer cells without harming healthy ones. The algae are a diatom and many diatoms look very cool.

Sadly the actual research paper (by government funded university professors) is published by a closed science publisher (when are we finally going to stop this practice that was outdated over a decade ago?). Thankfully those responsible for SciShow are much more interested in promoting science than maintaining outdated business models (in direct contrast to so many science journal publishers).

Related post on cool delivery methods for life saving drugs: Using Bacteria to Carry Nanoparticles Into CellsSelf-Assembling Cubes Could Deliver Medicine (2006)Nanoparticles With Scorpion Venom Slow Cancer SpreadNASA Biocapsules Deliver Medical Interventions Based Upon What They Detect in the Body

Parasite Evolved from Cnidarians (Jellyfish etc.)

This is another instance of science research providing us interesting details about the very odd ways life has evolved on earth.

Genome sequencing confirms that myxozoans, a diverse group of microscopic parasites that infect invertebrate and vertebrate hosts, are actually highly reduced cnidarians — the phylum that includes jellyfish, corals and sea anemones.

“This is a remarkable case of extreme degeneration of an animal body plan,” said Paulyn Cartwright, associate professor of ecology and evolutionary biology at the University of Kansas (KU) and principal investigator on the research project. “First, we confirmed they’re cnidarians. Now we need to investigate how they got to be that way.”

images of myxozoans parasite spores and a jellyfish

Not only has the parasitic micro jellyfish evolved a stripped-down body plan of just a few cells, but via data generated at the KU Medical Center’s Genome Sequencing Facility researchers also found the myxozoan genome was drastically simplified.

“These were 20 to 40 times smaller than average jellyfish genomes,” Cartwright said. “It’s one of the smallest animal genomes ever reported. It only has about 20 million base pairs, whereas the average Cnidarian has over 300 million. These are tiny little genomes by comparison.”

Despite its radical phasedown of the modern jellyfish’s body structure and genome over millions of years, Myxozoa has retained the essential characteristic of the jellyfish — its stinger, or “nematocyst” — along with the genes needed to make it.

“Because they’re so weird, it’s difficult to imagine they were jellyfish,” she said. “They don’t have a mouth or a gut. They have just a few cells. But then they have this complex structure that looks just like stinging cell of cnidarian. Jellyfish tentacles are loaded with them — little firing weapons.”

The findings are the stuff of scientific fascination but also could have a commercial effect. Myxozoa commonly plague commercial fish stock such as trout and salmon.

“They’re a very diverse group of parasites, and some have been well-studied because they infect fish and can wreak havoc in aquaculture of economic importance,” Cartwright said.

Continue reading

200,000 People Die Every Year in Europe from Adverse Drug Effects – How Can We Improve?

A new integrated computational method helps predicting adverse drug reaction more reliably than with traditional computing methods. This improved ability to foresee the possible adverse effects of drugs may entail saving many lives in the future.

Most computer tools employed today to detect possible adverse effects of compounds that are candidates for new medicines are based on detecting labile fragments in the drug’s structure. These fragments can potentially transform to form reactive metabolites, which can have toxic properties. This is what is known as idiosyncratic toxicity and is a big headache for the pharmaceutical industry, as it tends to be detected in late development stages of the drug and even when it is already on the market, often causing the drug to be withdrawn.

Jordi Mestres, coordinator of the IMIM and UPF research group on Systems Pharmacology at the Biomedical Informatics Program (GRIB) states ‘With this study we have contributed to complementing the detection of these quite unstable fragments, with information on the mechanism of action of the drug, based on three aspects: similarity to other medicines, prediction of their pharmacological profile, and interference with specific biological pathways. The optimal integration of these four aspects results in a clear improvement of our ability to anticipate adverse effects with higher confidence, which entails an extremely positive impact on society’.

In Europe, nearly 200,000 people die every year from adverse drug reactions, seven times more than in traffic accidents. An estimated 5% of hospitalisations are due to adverse effects and they are the fifth most common cause of hospital death. In addition, elderly people tend to take more than one drug at the same time, which multiplies the chances of suffering from adverse effects due to potential drug-drug interactions. In an increasingly aging society, this problem is becoming much more serious.

I think interactions is a hugely important area that needs a great deal more research. Doing so is very complex, which means it isn’t surprising so much more work is needed. The work of my father (and George Box and others) on multi-factorial experimentation is a powerful tool to aid this work (and that connection is likely one of the reasons I find the area of interactions so interesting – along with the realization there is so much benefit possible if we focus in that area more). Previous post on this Curious Cat Science and Engineering blog: Introduction to Fractional Factorial Designed Experiments.

The human and financial costs of adverse effects are very high. That is why the discovery of new medicines is increasingly focused more on predicting possible adverse effects at the initial stages of developing a new drug. This work hopes to contribute to setting the path toward a new generation of more reliable computational tools with regard to predicting the adverse effects of therapeutically-relevant small molecules. Advancing large-scale predictive safety at the pre-clinical phase is now becoming closer than ever, with expectations to lead to safer drugs for the entire population.

The research is published in closed science journal so I don’t link to it. I happily link to open science publications. Read the full press release which includes a link to the closed science journal.

Related: Lifestyle Drugs and RiskRoot Cause, Interactions, Robustness and Design of ExperimentsOne factor at a time (OFAT) Versus Factorial DesignsThe Purpose of Mulit-Factorial Designed Experiments11 Year Old Using Design of ExperimentsOver-reliance on Prescription Drugs to Aid Children’s Sleep?

Fighting Superbugs with Superhero Bugs

As concerns over deadly antibiotic-resistant strains of ‘superbug’ bacteria grow, scientists at the Salk Institute are offering a possible solution to the problem: ‘superhero’ bacteria that live in the gut and move to other parts of the body to alleviate life-threatening side effects caused by infections.

Salk researchers reported finding a strain of microbiome Escherichia coli bacteria in mice capable of improving the animals’ tolerance to infections of the lungs and intestines by preventing wasting–a common and potentially deadly loss of muscle tissue that occurs in serious infections. If a similarly protective strain is found in humans, it could offer a new avenue for countering muscle wasting, which afflicts patients suffering from sepsis and hospital-acquired infections, many of which are now antibiotic resistant.

images of E. coli bacteria, salmonella typhimurium and burkholderia thailandensis

Salk scientists found a strain of E. coli bacteria (left) that were able to stop muscle wasting in mice infected with either Salmonella Typhimurium (center) and Burkholderia thailandensis (right). Image courtesy the Salk Institute.

“Treatments for infection have long focused on eradicating the offending microbe, but what actually kills people aren’t the bacteria themselves–it’s the collateral damage it does to the body,” says Janelle Ayres, a Salk assistant professor in the Nomis Foundation Laboratories for Immunobiology and Microbial Pathogenesis and senior researcher on the study.

“Our findings suggest that preventing the damage–in this case muscle wasting–can stave off the most life-threatening aspects of an infection,” she adds. “And by not trying the kill the pathogen, you’re not encouraging the evolution of the deadly antibiotic-resistant strains that are killing people around the world. We might be able to fight superbugs with ‘superhero’ bugs.”

Once the most powerful and revolutionary of drugs, antibiotics appear to have reached their limits, due to the ability of bacteria to rapidly evolve resistance to the medicines. The rise of antibiotic resistance presents a grave threat to people around the world, as diseases once easily controlled repel all attempts at treatment. A recent study found that up to half of the bacteria that cause infections in US hospitals after a surgery are resistant to standard antibiotics.

In the United States alone, two million people annually become infected with bacteria that are resistant to antibiotics and at least 23,000 people die each year as a direct result of these infections, according to the U.S. Centers for Disease Control.

Continue reading

Funding Sources for Independent Postdoctoral Research Projects in Biology

Here is a nice list of funding sources for independent postdoctoral research projects in biology.

Some examples:

Directory of select science and engineering scholarships and fellowships for undergraduates, graduates and faculty on our blog.

Related: Science, Engineering and Math Fellowships (2008)Proposal to Triple NSF GFRP Awards and the Size of the Awards by 33% (2007)HHMI Expands Support of Postdoctoral ScientistsNSF Graduate Research Fellow Profiles (Sergy Brin, Google co-founder)

Youyou Tu: The First Chinese Woman to Win a Nobel Prize

The Nobel Prize in Physiology or Medicine 2015 was divided, one half jointly to William C. Campbell (born Ireland, now USA) and Satoshi Ōmura (Japan) “for their discoveries concerning a novel therapy against infections caused by roundworm parasites” and the other half to Youyou Tu (China) “for her discoveries concerning a novel therapy against Malaria”.

Youyou Tu is the first Chinese woman to win a Nobel Prize.

Diseases caused by parasites have plagued humankind for millennia and constitute a major global health problem. In particular, parasitic diseases affect the world’s poorest populations and represent a huge barrier to improving human health and wellbeing. This year’s Nobel Laureates have developed therapies that have revolutionized the treatment of some of the most devastating parasitic diseases.

William C. Campbell and Satoshi Ōmura discovered a new drug, Avermectin, the derivatives of which have radically lowered the incidence of River Blindness and Lymphatic Filariasis, as well as showing efficacy against an expanding number of other parasitic diseases. Youyou Tu discovered Artemisinin, a drug that has significantly reduced the mortality rates for patients suffering from Malaria.

These two discoveries have provided humankind with powerful new means to combat these debilitating diseases that affect hundreds of millions of people annually. The consequences in terms of improved human health and reduced suffering are immeasurable.

image of Artemisinin

via Noble Prize website

Malaria was traditionally treated by chloroquine or quinine, but with declining success. By the late 1960s, efforts to eradicate Malaria had failed and the disease was on the rise. At that time, Youyou Tu in China turned to traditional herbal medicine to tackle the challenge of developing novel Malaria therapies. From a large-scale screen of herbal remedies in Malaria-infected animals, an extract from the plant Artemisia annua emerged as an interesting candidate.

However, the results were inconsistent, so Tu revisited the ancient literature and discovered clues that guided her in her quest to successfully extract the active component from Artemisia annua. Tu was the first to show that this component, later called Artemisinin, was highly effective against the Malaria parasite, both in infected animals and in humans. Artemisinin represents a new class of antimalarial agents that rapidly kill the Malaria parasites at an early stage of their development, which explains its unprecedented potency in the treatment of severe Malaria.

Youyou Tu was born in 1930 in China and is a Chinese citizen. She graduated from the Pharmacy Department at Beijing Medical University in 1955. From 1965-1978 she was Assistant Professor at the China Academy of Traditional Chinese Medicine, from 1979-1984 Associate Professor and from 1985 Professor at the same Institute. From 2000, Tu has been Chief Professor at the China Academy of Traditional Chinese Medicine. She doesn’t have a doctorate, very rare for a Nobel Prize winner in the sciences.

Read the full press release

Related: Nobel Prize in Physiology or Medicine 2012 for Reprogramming Cells to be PluripotentNobel Prize in Physiology or Medicine 2008Parasites in the Gut Help Develop a Healthy Immune System2011 Nobel Prize in Physiology or MedicineVideo showing malaria breaking into cell

Cancer Rates Consistent Across Species Instead of Increasing Due to Body Mass

It would seem sensible to think cancer should be more prevalent in species with a huge number of cells, and thus more cells to become cancerous. But cancer risk doesn’t increase in this way. This interesting, open source paper, sheds some light on what is behind this.

Solutions to Peto’s paradox revealed by mathematical modelling and cross-species cancer gene analysis

Whales have 1000-fold more cells than humans and mice have 1000-fold fewer; however, cancer risk across species does not increase with the number of somatic cells and the lifespan of the organism. This observation is known as Peto’s paradox. How much would evolution have to change the parameters of somatic evolution in order to equalize the cancer risk between species that differ by orders of magnitude in size? Analysis of previously published models of colorectal cancer suggests that a two- to three-fold decrease in the mutation rate or stem cell division rate is enough to reduce a whale’s cancer risk to that of a human. Similarly, the addition of one to two required tumour-suppressor gene mutations would also be sufficient.

We surveyed mammalian genomes and did not find a positive correlation of tumour-suppressor genes with increasing body mass and longevity. However, we found evidence of the amplification of TP53 in elephants, MAL in horses and FBXO31 in microbats, which might explain Peto’s paradox in those species. Exploring parameters that evolution may have fine-tuned in large, long-lived organisms will help guide future experiments to reveal the underlying biology responsible for Peto’s paradox and guide cancer prevention in humans.

Elephants in Kenya

Elephants in Kenya by John Hunter. See more photos from my trip to Kenya.

In another way it would make sense that large animals would have hugely increased risks of cancer. As they evolved, extremely high cancer rates would be a much bigger problem for them. Therefore it wouldn’t be surprising to find they have evolved a way of reducing cancer risks.

Despite these limitations, we found genes that have been dramatically amplified in specific mammalian genomes, the most interesting of which is the discovery of 12 TP53 copies in the genome of the African elephant. We subsequently cloned those genes and identified 19 distinct copies of TP53 in African elephants and 15–20 in Asian elephants [1]. Another potential lead for solving Peto’s paradox is MAL, which is found to have eight copies in the horse genome and two in microbat. This could be an example of convergent evolution where a large animal (horse) and a small, long-lived animal (microbat) both evolved extra copies of the same gene to overcome their increased risk of cancer. Further analysis and experimentation would need to be performed to determine the function of these copies and whether or not they provide enhanced suppression of carcinogenesis.

The researchers have found an interesting potential explanation for how that has been accomplished.

Related: The Only Known Cancerless Animal (the naked mole rat)Webcast of a T-cell Killing a Cancerous CellResearchers Find Switch That Allows Cancer Cells to SpreadCancer Vaccines

In Many Crops Ants Can Provide Pest Protection Superior or Equal to Chemicals at a Much Lower Cost

Ants are as Effective as pesticides

The review [of over 70 studies] was conducted by Aarhus University’s Dr Joachim Offenberg, an ecologist who has studied ants for almost 20 years. It includes studies of more than 50 pest species on nine crops across eight countries in Africa, South-East Asia and Australia.

Most of the studies in Offenberg’s review are on weaver ants (Oecophylla), a tropical species which lives in trees and weaves ball-shaped nests from leaves. Because weaver ants live in their host trees’ canopy, near the flowers and fruit that need protection from pests, they are good pest controllers in tropical orchards.

All farmers need to do is collect ant nests from the wild, hang them in plastic bags among their tree crops and feed them a sugar solution while they build their new nests. Once a colony is established, farmers then connect the trees that are part of the colony with aerial ‘ant walkways’ made from string or lianas.

After that, the ants need little, except for some water in the dry season (which can be provided by hanging old plastic bottles among the trees), pruning trees that belong to different colonies so that the ants do not fight, and avoiding insecticide sprays.

The review shows that crops such as cashew and mango can be exceptionally well protected from pests by weaver ants.

One three-year study in Australia recorded cashew yields 49% higher in plots patrolled by ants compared with those protected by chemicals. Nut quality was higher too, so net income was 71% higher with ants than with chemicals.

Similar studies in Australian mango crops found that ants could produce the same yield as chemical control, but because the ants were cheaper, and fruit quality better, net income from mangoes produced with ant protection was 73% higher.

Those crops are special cases in which the ants are vastly superior. But in many other cases ants are as effective and much cheaper than chemical options. Different species of ants are suited to protecting different types of drops. Weaver ants require a canopy, other ants can protect crops without a canopy.

I hope more farmers adopt ants to help protect their crop yields.

Related: Pigs Instead of PesticidesWhy Don’t All Ant Species Replace Queens in the Colony, Since Some DoHow To Make Your Own Pesticide with Ingredients from Your KitchenAnother Bee Study Finds CCD is Likely Due to Combination of Factors Including Pesticides (2013)

Lexus Has Built a Working Hoverboard

Toyota continues to do some fun and interesting research while they produce great cars (and make a lot of money doing so that allows them resources to do interesting research). Some past posts on their engineering exploits: Toyota Develops Thought-controlled Wheelchair (2009), Toyota Engineering Development Process, Innovation at Toyota, How to Develop Products like Toyota, Toyota IT Overview.

Toyota is teasing with the hoverboard announcement but it seems they have actually created it (though it isn’t ready to be in stores this year.

Liquid nitrogen cooled superconductors and permanent magnets combine to power the Lexus Hoverboard.

Sadly they haven’t bothered to hire a decent web designer. They have a pretty but broken website, with essentially no information. It is sad when interesting stories are keep to nearly no information using poorly designed websites created by people obviously more concerned with old fashion paper design thinking than how the web can be used to be clear and useful (not just pretty).

Pretty much for the last 10 years Toyota has had pretty but web hostile design for their web sites. It is a shame they can’t hire people that know how to properly create good web sites. Thankfully they hire good engineers and use good processes to actually develop products.

Intel International Science and Engineering Fair 2015

Raymond Wang, 17, of Canada was awarded first place for engineering a new air inlet system for airplane cabins to improve air quality and curb disease transmission at this year’s Intel International Science and Engineering Fair.

Wang’s system improves the availability of fresh air in the cabin by more than 190% while reducing pathogen inhalation concentrations by up to 55 times compared to conventional designs, and can be easily and economically incorporated in existing airplanes. Wang received the Gordon E. Moore Award of US$75,000. The system uses vents to create a “bubble” around passengers that deflects incoming air.

Nicole Ticea, 16, of Canada received one of two Intel Foundation Young Scientist Awards of US$50,000 for developing an inexpensive, easy-to-use testing device to combat the high rate of undiagnosed HIV infection in low-income communities. Her disposable, electricity-free device provides results in an hour and should cost less than US$5 to produce. Ticea has already founded her own company, which recently received a US$100,000 grant to continue developing her technology.

Karan Jerath, 18, of Friendswood, Texas, received the other Intel Foundation Young Scientist Award of US$50,000 for refining and testing a novel device that should allow an undersea oil well to rapidly and safely recover following a blowout. Jerath developed a better containment enclosure that separates the natural gas, oil and ocean water; accommodates different water depths, pipe sizes and fluid compositions; and can prevent the formation of potentially clogging methane hydrate.

This year’s Intel International Science and Engineering Fair featured approximately 1,700 young scientists selected from 422 affiliate fairs in more than 75 countries, regions and territories.

Related: Intel Science Talent Search 2012 AwardeesGreat Projects From First Google Science Fair Finalists (2011)2008 Intel Science Talent SearchHigh School Student Creates: Test That is Much More Accurate and 26,000 Times Cheaper Than Existing Pancreatic Cancer Tests

  • Recent Comments:

    • Jack Lawson: Wow! Awesome article and very entertaining story about insects. Animals are awesome! Keep it...
    • Mehmet: I think governments should encourage people for such initiatives.
    • Anonymous: It looks like a bird like a woodpecker. I do not know the name, but I have a perfect creation.
    • David: Very interesting story about the architecture of insects. They create very interesting shapes.
    • Mon Roi: Instead of marketing DVD sets or VHS sets or whatever else they just give it up for free. There is...
    • Gebze Pansiyon: Woww…. what a beautiful bird. I love the picture.
    • Vignesh P: very useful information.thank you for sharing It is so good blog !
    • Dustin McEarchern: Love the use of technology to improve lives. Really great story.
  • Recent Trackbacks:

  • Links